Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Sureda

Showing results (121-130 of 380) with videos related to

Pageof 38
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 3, 2005
Reduced-intensity conditioning allogeneic blood stem cell transplantation with fludarabine and oral busulfan with or without pharmacokinetically targeted busulfan dosing in patients with myeloid leukemia ineligible for conventional conditioningRodrigo Martino, José A Pérez-Simón, Estela Moreno, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 19, 2007
Reduced-intensity conditioning compared with conventional allogeneic stem-cell transplantation in relapsed or refractory Hodgkin's lymphoma: an analysis from the Lymphoma Working Party of the European Group for Blood and Marrow TransplantationAnna Sureda, Stephen Robinson, Carmen Canals, et al.
Haematologica|May 29, 2002
Different patterns of relapse after autologous peripheral blood stem cell transplantation in multiple myeloma: clinical results of 280 cases from the Spanish RegistryAdrián Alegre, Asunción Granda, Carmen Martínez-Chamorro, et al.
International Journal of Hematology|November 30, 2022
Front-line fludarabine-cyclophosphamide-rituximab (FCR) in 110 patients with chronic lymphocytic leukaemia (CLL): real-life experience with long-term outcomes, toxicities and responses to second-line therapiesAna C Oliveira, Josep Maria Roncero, Christelle Ferrá, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2012
Autologous and allogeneic stem-cell transplantation for transformed chronic lymphocytic leukemia (Richter's syndrome): A retrospective analysis from the chronic lymphocytic leukemia subcommittee of the chronic leukemia working party and lymphoma working party of the European Group for Blood and Marrow TransplantationKate Cwynarski, Anja van Biezen, Liesbeth de Wreede, et al.
Haematologica|January 29, 2010
Reduced intensity conditioning HLA identical sibling donor allogeneic stem cell transplantation for patients with follicular lymphoma: long-term follow-up from two prospective multicenter trialsJosé Luis Piñana, Rodrigo Martino, Jorge Gayoso, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 23, 2008
The effect of in vivo T cell depletion with alemtuzumab on reduced-intensity allogeneic hematopoietic cell transplantation for chronic lymphocytic leukemiaJulio Delgado, Srinivas Pillai, Reuben Benjamin, et al.
Haematologica|June 13, 2003
International and Italian prognostic indices in follicular lymphomaGranada Perea, Albert Altés, Silvia Montoto, et al.
Bone Marrow Transplantation|June 3, 2026
Defining lines of therapy in haematological malignancies: a proposed systematic and comprehensive framework from the EBMT Practice Harmonisation and Guidelines CommitteeAlessandro Criscimanna, Jacques-Emanuel Galimard, Isabel Sánchez-Ortega, et al.
Leukemia & Lymphoma|April 23, 2015
High-dose therapy and autologous stem cell transplantation for extra-nodal NK/T lymphoma in patients from the Western hemisphere: a study from the European Society for Blood and Marrow TransplantationChristopher P Fox, Ariane Boumendil, Norbert Schmitz, et al.
Pageof 38

Showing results (121-130 of 380) with videos related to

Sort By:
Pageof 38
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 3, 2005
Reduced-intensity conditioning allogeneic blood stem cell transplantation with fludarabine and oral busulfan with or without pharmacokinetically targeted busulfan dosing in patients with myeloid leukemia ineligible for conventional conditioningRodrigo Martino, José A Pérez-Simón, Estela Moreno, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 19, 2007
Reduced-intensity conditioning compared with conventional allogeneic stem-cell transplantation in relapsed or refractory Hodgkin's lymphoma: an analysis from the Lymphoma Working Party of the European Group for Blood and Marrow TransplantationAnna Sureda, Stephen Robinson, Carmen Canals, et al.
Haematologica|May 29, 2002
Different patterns of relapse after autologous peripheral blood stem cell transplantation in multiple myeloma: clinical results of 280 cases from the Spanish RegistryAdrián Alegre, Asunción Granda, Carmen Martínez-Chamorro, et al.
International Journal of Hematology|November 30, 2022
Front-line fludarabine-cyclophosphamide-rituximab (FCR) in 110 patients with chronic lymphocytic leukaemia (CLL): real-life experience with long-term outcomes, toxicities and responses to second-line therapiesAna C Oliveira, Josep Maria Roncero, Christelle Ferrá, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2012
Autologous and allogeneic stem-cell transplantation for transformed chronic lymphocytic leukemia (Richter's syndrome): A retrospective analysis from the chronic lymphocytic leukemia subcommittee of the chronic leukemia working party and lymphoma working party of the European Group for Blood and Marrow TransplantationKate Cwynarski, Anja van Biezen, Liesbeth de Wreede, et al.
Haematologica|January 29, 2010
Reduced intensity conditioning HLA identical sibling donor allogeneic stem cell transplantation for patients with follicular lymphoma: long-term follow-up from two prospective multicenter trialsJosé Luis Piñana, Rodrigo Martino, Jorge Gayoso, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 23, 2008
The effect of in vivo T cell depletion with alemtuzumab on reduced-intensity allogeneic hematopoietic cell transplantation for chronic lymphocytic leukemiaJulio Delgado, Srinivas Pillai, Reuben Benjamin, et al.
Haematologica|June 13, 2003
International and Italian prognostic indices in follicular lymphomaGranada Perea, Albert Altés, Silvia Montoto, et al.
Bone Marrow Transplantation|June 3, 2026
Defining lines of therapy in haematological malignancies: a proposed systematic and comprehensive framework from the EBMT Practice Harmonisation and Guidelines CommitteeAlessandro Criscimanna, Jacques-Emanuel Galimard, Isabel Sánchez-Ortega, et al.
Leukemia & Lymphoma|April 23, 2015
High-dose therapy and autologous stem cell transplantation for extra-nodal NK/T lymphoma in patients from the Western hemisphere: a study from the European Society for Blood and Marrow TransplantationChristopher P Fox, Ariane Boumendil, Norbert Schmitz, et al.
Pageof 38